Floatz logo

Bxcl501

Sleep Apnea

American University of Beirut Medical CenterPhase 2/3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the Sleep Apnea cohort.

Asset / SponsorPhaseRating
Trazodone
Chang Gung Memorial Hospital
Phase 4BB
PROPOFOL
Icahn School of Medicine at Mount Sinai
Phase 4BB
VALSARTAN
University Hospital, Grenoble
Phase 4BB
AMLODIPINE
University Hospital, Grenoble
Phase 4BB
Mazdutide
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3B

View all 18 →

Same molecule, other indications

Bxcl501 is also rated in:

Pain, ChronicDormant
A
Indicative ·
80 / 100
View asset →
Agitation,PsychomotorDormant
A
Indicative ·
80 / 100
View asset →
schizophreniform disorderDormant
A
Indicative ·
80 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →